These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model. San Román B; De Andrés X; Muñoz PM; Obregón P; Asensio AC; Garrido V; Mansilla C; Arribillaga L; Lasarte JJ; De Andrés D; Amorena B; Grilló MJ Vaccine; 2012 Mar; 30(15):2564-9. PubMed ID: 22326778 [TBL] [Abstract][Full Text] [Related]
27. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. Gupta NK; Tomar P; Sharma V; Dixit VK Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718 [TBL] [Abstract][Full Text] [Related]
28. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules. Saini V; Verma AK; Kushwaha V; Joseph SK; Murthy PK; Kohli D Drug Deliv; 2014 May; 21(3):233-41. PubMed ID: 24171405 [TBL] [Abstract][Full Text] [Related]
29. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. Cui Z; Mumper RJ Int J Pharm; 2002 May; 238(1-2):229-39. PubMed ID: 11996826 [TBL] [Abstract][Full Text] [Related]
30. Nasal vaccination with poly(β-amino ester)-poly(d,l-lactide-co-glycolide) hybrid nanoparticles. Sinani G; Sessevmez M; Koray Gök M; Özgümüş S; Okyar A; Oya Alpar H; Cevher E Int J Pharm; 2017 Aug; 529(1-2):1-14. PubMed ID: 28629979 [TBL] [Abstract][Full Text] [Related]
31. Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(d,l-lactic acid) nanospheres. Zheng S; Qin T; Lu Y; Huang Y; Luo L; Liu Z; Bo R; Hu Y; Liu J; Wang D Int J Nanomedicine; 2018; 13():569-583. PubMed ID: 29416336 [TBL] [Abstract][Full Text] [Related]
32. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. Lutsiak ME; Kwon GS; Samuel J J Pharm Pharmacol; 2006 Jun; 58(6):739-47. PubMed ID: 16734975 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. Suzue K; Young RA J Immunol; 1996 Jan; 156(2):873-9. PubMed ID: 8543845 [TBL] [Abstract][Full Text] [Related]
34. Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Wang Q; Sun X; Huang X; Huang J; Hasan MW; Yan R; Xu L; Song X; Li X Int J Nanomedicine; 2021; 16():3125-3139. PubMed ID: 33981142 [TBL] [Abstract][Full Text] [Related]
35. Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells. Rancan F; Amselgruber S; Hadam S; Munier S; Pavot V; Verrier B; Hackbarth S; Combadiere B; Blume-Peytavi U; Vogt A J Control Release; 2014 Feb; 176():115-22. PubMed ID: 24384300 [TBL] [Abstract][Full Text] [Related]
36. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Stivaktakis N; Nikou K; Panagi Z; Beletsi A; Leondiadis L; Avgoustakis K J Biomed Mater Res A; 2005 Jun; 73(3):332-8. PubMed ID: 15793820 [TBL] [Abstract][Full Text] [Related]
37. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. Jain AK; Goyal AK; Gupta PN; Khatri K; Mishra N; Mehta A; Mangal S; Vyas SP J Control Release; 2009 Jun; 136(2):161-9. PubMed ID: 19239919 [TBL] [Abstract][Full Text] [Related]
39. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes. Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267 [TBL] [Abstract][Full Text] [Related]
40. Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells. Rochereau N; Pavot V; Verrier B; Ensinas A; Genin C; Corthésy B; Paul S Eur J Immunol; 2015 Mar; 45(3):773-9. PubMed ID: 25412898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]